Close Menu

NEW YORK (GenomeWeb) – Pangea Laboratory said yesterday that it has licensed a urine-based laboratory-developed test for bladder cancer detection from Zymo Research.

Commercialized and sold under the name Bladder Care, the test uses qPCR to measure the methylation level of three bladder cancer-specific biomarkers in patient urine samples that can be collected at home or in a physician's office.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.